Literature DB >> 11782604

Gastrointestinal uses of botulinum toxin.

Waqar A Qureshi1.   

Abstract

Botulinum toxin was initially used in medicine to produce a potent neuromuscular blockade. It was later found to interfere with acetylcholine release in the myenteric plexus and inhibit contraction in gastrointestinal smooth muscle, leading to its use in the treatment of various conditions. It is frequently used in the treatment of achalasia in elderly patients who may be poor surgical candidates. It has been used successfully in the management of various conditions, including anal fissure and biliary dyskinesia. Large controlled trials are needed to establish the role of botulinum toxin and its safety in gastroenterology.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11782604     DOI: 10.1097/00004836-200202000-00004

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  3 in total

1.  The changed image of botulinum toxin.

Authors:  V Peter Misra
Journal:  BMJ       Date:  2002-11-23

2.  Endoscopic ultrasound-guided gastric botulinum toxin injections in obese subjects: a pilot study.

Authors:  Mark Topazian; Michael Camilleri; Jose De La Mora-Levy; Felicity B Enders; Amy E Foxx-Orenstein; Michael J Levy; Vandana Nehra; Nicholas J Talley
Journal:  Obes Surg       Date:  2008-02-20       Impact factor: 4.129

Review 3.  Clinical uses of botulinum neurotoxins: current indications, limitations and future developments.

Authors:  Sheng Chen
Journal:  Toxins (Basel)       Date:  2012-10-19       Impact factor: 4.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.